Search Ontology:
ChEBI
erythromycin A
- Term ID
- CHEBI:42355
- Synonyms
-
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxa
- 3''-O-demethylerythromycin
- Abomacetin
- eritromicina
- erthromycin
- erythromycin
- ERYTHROMYCIN A
- Erythromycin C
- erythromycine
- erythromycinum
- Definition
- An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.
- References
-
- Beilstein:75000
- Beilstein:75279
- CAS:114-07-8
- CAS:1675-02-1
- DrugBank:DB00199
- Drug_Central:1048
- KEGG:C01912
- KEGG:D00140
- LINCS:LSM-3416
- LIPID_MAPS_instance:LMPK04000006
- MetaCyc:CPD-13804
- PDBeChem:ERY
- Patent:US2823203
- Reaxys:75279
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_functional_parent
-
- inverse has_functional_parent
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from erythromycin A
Phenotype where environments contain erythromycin A
Phenotype modified by environments containing erythromycin A
Human Disease Model